AdventHealth - Blood & Marrow Transplant Center (East Orlando)

Orlando, FL

Accepting patients

SX-682

A Phase 1, Open-Label, Dose-Escalation With Expansion Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Learn more
  • CXCR1 Inhibitor
  • CXCR2 Inhibitor
  • Phase 1
  • Has results
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials